{"id":"W2284051918","doi":"10.1155/2004/394710","title":"The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment","year":2004,"lang":"en","type":"article","venue":"Canadian Respiratory Journal","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Dalhousie University; University of Toronto; McGill University; University of British Columbia; Ottawa Hospital; Université Laval; University of Ottawa","funders":"","keywords":"Medicine; Salmeterol; COPD; Exacerbation; Placebo; Randomized controlled trial; Bronchodilator; Randomization; Quality of life (healthcare); Clinical trial; Physical therapy; Salbutamol; Tiotropium bromide; Inhaler; Intensive care medicine; Fluticasone propionate; Internal medicine; Asthma; Lung function; Lung; Alternative medicine; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01419085,0.002616726,0.004047778,0.0008951157,0.003557958,0.00176998,0.002152267,0.003852063,0.0159556],"category_scores_gemma":[0.02051974,0.001260027,0.002443236,0.00227152,0.002460684,0.001150694,0.00167642,0.001977844,0.001110017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01979599,"about_ca_system_score_gemma":0.06660487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4798039,"about_ca_topic_score_gemma":0.63742,"domain_scores_codex":[0.9875065,0.007253312,0.0005910379,0.001147087,0.002335984,0.001165975],"domain_scores_gemma":[0.9956528,0.000991815,0.0006611292,0.0005341967,0.00119256,0.0009675035],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.7448988,0.003717341,0.0138032,0.01046189,0.005233176,0.0003036264,0.0004796613,0.004479926,0.000724646,0.01489442,0.1215235,0.07947975],"study_design_scores_gemma":[0.9107988,0.01057864,0.02056146,0.0009826161,0.003566018,0.0001595553,0.0001293595,0.003263021,0.0002449562,0.004571957,0.04489526,0.000248327],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.3200596,0.05862003,0.01556522,0.02980431,0.005691424,0.4174671,0.07326867,0.0009263902,0.07859733],"genre_scores_gemma":[0.4725215,0.009015833,0.04004392,0.01122372,0.001323816,0.4305609,0.0144923,0.0001582446,0.02065964],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.4798039,"threshold_uncertainty_score":0.9540223,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0678869673666407,"score_gpt":0.3069675780693554,"score_spread":0.2390806107027147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}